Asena Esra Erdem
Research Subjects
Asena Esra Erdem has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Barış SAREYYÜPOĞLU
ANKARA ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ, KLİNİK ÖNCESİ BİLİMLERİ BÖLÜMÜ, VETERİNERLİK MİKROBİYOLOJİSİ ANABİLİM DALI
1 shared publication - Hamit Kaan Müştak
Department of Microbiology, Faculty of Veterinary Medicine, Ankara University, Ankara, 06070, Türkiye
1 shared publication - Seyyide Sarıçam İnce
Faculty of Veterinary Medicine, Department of Microbiology, Ankara University, TR-06110 Ankara, Türkiye
1 shared publication - Tuğçe ÜSTÜN
ANKARA UNIVERSITY, ANKARA FACULTY OF VETERINARY MEDICINE
1 shared publication - İnci Başak Müştak
Department of Microbiology, Faculty of Veterinary Medicine Ankara University Ankara Türkiye
1 shared publication
Latest Publications
- 15 June 2022
- Published by Etlik Veteriner Mikrobiyoloji Dergisi in Etlik Veteriner Mikrobiyoloji Dergisi
- Vol. 33 (1) , 102-109
DIVA (Differentiating Infected from Vaccinated Animals) Aşı ve Stratejileri
In veterinary medicine, vaccination is one of the most effective techniques for control and prevention of diseases. When other methods fail in control of animal diseases, different vaccines and strategies are developed. DIVA (Differentiating Infected from Vaccinated Animals) vaccines lacking one or more antigenic epitope(s)/ protein(s) in the prevailing field strain and the accompanying diagnostic tests are effective in eradication and control of diseases. While currently used vaccines can not distinguish between vaccinated and infected animals, DIVA vaccines can be very useful for the purpose. Serological tests, such as ELISA (Enzyme-Linked ImmunoSorbent Assay), used together with DIVA vaccines, can be used to determine which animals are infected and which are vaccinated. DIVA vaccines and strategies for some animal diseases have been developed and continue to be developed. In this review, it is aimed to explain the general characteristics, importance, production, advantages of DIVA vaccines and strategies and their use in various animal diseases.
- 15 June 2022
- Published by Etlik Veteriner Mikrobiyoloji Dergisi in Etlik Veteriner Mikrobiyoloji Dergisi
- Vol. 33 (1) , 102-109
DIVA (Differentiating Infected from Vaccinated Animals) Aşı ve Stratejileri
In veterinary medicine, vaccination is one of the most effective techniques for control and prevention of diseases. When other methods fail in control of animal diseases, different vaccines and strategies are developed. DIVA (Differentiating Infected from Vaccinated Animals) vaccines lacking one or more antigenic epitope(s)/ protein(s) in the prevailing field strain and the accompanying diagnostic tests are effective in eradication and control of diseases. While currently used vaccines can not distinguish between vaccinated and infected animals, DIVA vaccines can be very useful for the purpose. Serological tests, such as ELISA (Enzyme-Linked ImmunoSorbent Assay), used together with DIVA vaccines, can be used to determine which animals are infected and which are vaccinated. DIVA vaccines and strategies for some animal diseases have been developed and continue to be developed. In this review, it is aimed to explain the general characteristics, importance, production, advantages of DIVA vaccines and strategies and their use in various animal diseases.
- 31 December 2020
- Published by Etlik Veteriner Mikrobiyoloji Dergisi in Etlik Veteriner Mikrobiyoloji Dergisi
- Vol. 31 (2) , 127-132
Frequency of Staphylococcus pseudintermedius in Canine Skin Infections and Antibiotic Resistance Profiles of the Recovered Isolates
In this study, 61 Staphylococcus pseudintermedius strains were isolated from 77 dogs with skin infections. Antimicrobial resistance to commonly used antibiotics was evaluated by disc diffusion method. The presence of the blaZ and mecA genes responsible respectively for penicillin and methicillin resistance were investigated by PCR. The S. pseudintermedius isolates were highly resistant to tetracycline (47.5%) and penicillin (40.9%) while all isolates were susceptible to amikacin (100%). All 18 methicillin-resistant S. pseudintermedius (MRSP) strains were positive for the mecA gene while the 25 S. pseudintermedius strain isolates with the blaZ gene were also resistant to penicillin phenotypically. Of the 18 MRSP isolates, 14 S. pseudintermedius strains were resistant to three or more antibiotics, indicating that these strains showed multiple drug resistance (MDR). This report confirms previous findings that S. pseudintermedius is the most frequently isolated bacteria from dog skin infections. It can also be concluded that amikacin is a useful agent for treating S. pseudintermedius infections since all the S. pseudintermedius strains tested in this study were susceptible to amikacin.
- 31 December 2020
- Published by Etlik Veteriner Mikrobiyoloji Dergisi in Etlik Veteriner Mikrobiyoloji Dergisi
- Vol. 31 (2) , 127-132
Frequency of Staphylococcus pseudintermedius in Canine Skin Infections and Antibiotic Resistance Profiles of the Recovered Isolates
In this study, 61 Staphylococcus pseudintermedius strains were isolated from 77 dogs with skin infections. Antimicrobial resistance to commonly used antibiotics was evaluated by disc diffusion method. The presence of the blaZ and mecA genes responsible respectively for penicillin and methicillin resistance were investigated by PCR. The S. pseudintermedius isolates were highly resistant to tetracycline (47.5%) and penicillin (40.9%) while all isolates were susceptible to amikacin (100%). All 18 methicillin-resistant S. pseudintermedius (MRSP) strains were positive for the mecA gene while the 25 S. pseudintermedius strain isolates with the blaZ gene were also resistant to penicillin phenotypically. Of the 18 MRSP isolates, 14 S. pseudintermedius strains were resistant to three or more antibiotics, indicating that these strains showed multiple drug resistance (MDR). This report confirms previous findings that S. pseudintermedius is the most frequently isolated bacteria from dog skin infections. It can also be concluded that amikacin is a useful agent for treating S. pseudintermedius infections since all the S. pseudintermedius strains tested in this study were susceptible to amikacin.